Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deepak Voora

Showing results (71-80 of 100) with videos related to

Pageof 10
Sort By:
Arteriosclerosis, Thrombosis, and Vascular Biology|December 7, 2023
Platelet RNA Biomarker of Ticagrelor-Responsive Genes Is Associated With Platelet Function and Cardiovascular EventsRachel A Myers, Thomas L Ortel, Alexander Waldrop, et al.
American Heart Journal|February 23, 2017
An age- and sex-specific gene expression score is associated with revascularization and coronary artery disease: Insights from the Prospective Multicenter Imaging Study for Evaluation of Chest Pain (PROMISE) trialDeepak Voora, Adrian Coles, Kerry L Lee, et al.
The American Journal of Cardiology|September 8, 2024
Association Between Lipoprotein(a) and Obstructive Coronary Artery Disease and High-Risk Plaque: Insights From the PROMISE TrialThomas O'Toole, Nishant P Shah, Stephanie Nicole Giamberardino, et al.
Blood|March 28, 2007
Genetic-based dosing in orthopedic patients beginning warfarin therapyEric A Millican, Petra A Lenzini, Paul E Milligan, et al.
JACC. Cardiovascular Imaging|August 4, 2022
Coronary Atherosclerosis, Cardiac Troponin, and Interleukin-6 in Patients With Chest Pain: The PROMISE Trial ResultsMaros Ferencik, Thomas Mayrhofer, Michael T Lu, et al.
Journal of Pharmaceutical Policy and Practice|December 12, 2023
Pharmacogenetic testing and monitoring of complete blood counts among Veterans newly prescribed thiopurine treatments: a retrospective cohort studyNai-Chung Nelson Chang, Catherine Chanfreau-Coffinier, Jill Bates, et al.
Pharmacogenomics|January 6, 2021
Veterans Affairs Pharmacogenomic Testing for Veterans (PHASER) clinical programOlivia M Dong, Jill Bates, Catherine Chanfreau-Coffinier, et al.
European Heart Journal|May 4, 2015
Effect of genetic variations on ticagrelor plasma levels and clinical outcomesChristoph Varenhorst, Niclas Eriksson, Åsa Johansson, et al.
JACC. Basic to Translational Science|October 24, 2024
Inhibiting the P2Y<sub>12</sub> Receptor in Megakaryocytes and Platelets Suppresses Interferon-Associated ResponsesMarcin A Sowa, Haoyu Sun, Tricia T Wang, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 25, 2020
Association of Hepatic Steatosis With Major Adverse Cardiovascular Events, Independent of Coronary Artery DiseaseNandini M Meyersohn, Thomas Mayrhofer, Kathleen E Corey, et al.
Pageof 10

Showing results (71-80 of 100) with videos related to

Sort By:
Pageof 10
Arteriosclerosis, Thrombosis, and Vascular Biology|December 7, 2023
Platelet RNA Biomarker of Ticagrelor-Responsive Genes Is Associated With Platelet Function and Cardiovascular EventsRachel A Myers, Thomas L Ortel, Alexander Waldrop, et al.
American Heart Journal|February 23, 2017
An age- and sex-specific gene expression score is associated with revascularization and coronary artery disease: Insights from the Prospective Multicenter Imaging Study for Evaluation of Chest Pain (PROMISE) trialDeepak Voora, Adrian Coles, Kerry L Lee, et al.
The American Journal of Cardiology|September 8, 2024
Association Between Lipoprotein(a) and Obstructive Coronary Artery Disease and High-Risk Plaque: Insights From the PROMISE TrialThomas O'Toole, Nishant P Shah, Stephanie Nicole Giamberardino, et al.
Blood|March 28, 2007
Genetic-based dosing in orthopedic patients beginning warfarin therapyEric A Millican, Petra A Lenzini, Paul E Milligan, et al.
JACC. Cardiovascular Imaging|August 4, 2022
Coronary Atherosclerosis, Cardiac Troponin, and Interleukin-6 in Patients With Chest Pain: The PROMISE Trial ResultsMaros Ferencik, Thomas Mayrhofer, Michael T Lu, et al.
Journal of Pharmaceutical Policy and Practice|December 12, 2023
Pharmacogenetic testing and monitoring of complete blood counts among Veterans newly prescribed thiopurine treatments: a retrospective cohort studyNai-Chung Nelson Chang, Catherine Chanfreau-Coffinier, Jill Bates, et al.
Pharmacogenomics|January 6, 2021
Veterans Affairs Pharmacogenomic Testing for Veterans (PHASER) clinical programOlivia M Dong, Jill Bates, Catherine Chanfreau-Coffinier, et al.
European Heart Journal|May 4, 2015
Effect of genetic variations on ticagrelor plasma levels and clinical outcomesChristoph Varenhorst, Niclas Eriksson, Åsa Johansson, et al.
JACC. Basic to Translational Science|October 24, 2024
Inhibiting the P2Y<sub>12</sub> Receptor in Megakaryocytes and Platelets Suppresses Interferon-Associated ResponsesMarcin A Sowa, Haoyu Sun, Tricia T Wang, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 25, 2020
Association of Hepatic Steatosis With Major Adverse Cardiovascular Events, Independent of Coronary Artery DiseaseNandini M Meyersohn, Thomas Mayrhofer, Kathleen E Corey, et al.
Pageof 10